Ravaka-Fatoma Soumoudronga

Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: a prospective multicentre study in France in patients with solid tumours (the ZOHé study)

Isabelle Gasnereau, M. Lamuraglia, H. Roché, 2018, BMC Cancer.

ZOHé: A Prospective Study of the Use of Biosimilar Filgrastim Zarzio in Clinical Practice in Patients Treated With Chemotherapy for Lymphoid Malignancies

C. Haioun, Isabelle Gasnereau, P. Solal-Céligny, 2017, Clinical lymphoma, myeloma & leukemia.

Zarzio®, biosimilar of filgrastim, in prophylaxis of chemotherapy-induced neutropenia in routine practice: a French prospective multicentric study

Isabelle Gasnereau, M. Ben Abdelghani, J. Labourey, 2015, Supportive Care in Cancer.

Gene Therapy in Patients with the Crigler-Najjar Syndrome.

P. Bosma, U. Baumann, N. Brunetti‐Pierri, 2023, The New England journal of medicine.